Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
JAEB CENTER FOR HEALTH RESEARCH FOUNDATION, INC.
Funding Organization
Temporal Graph
Map of Science
Research
Research
Awards Grant
Amblyopia Treatment Study (A TS20): Binocular Dig Rush Game Treatment for Amblyopia
Amblyopia Treatment Study - Augmenting Atropine Treatment (ATS)
Convergence Insufficiency Treatment Study: Effectiveness of Home Based Therapy for Symptomatic Convergence Insufficiency
Correction of Refractive Error for Amblyopia Protocol (XO1)
Hyperopia Treatment Study 1 (HTS1) Glasses Verses Observation for Moderate Hyperopia in Young Children: Pediatric Eye Disease Investigator Group
Hyperopia Treatment Study 1: Glasses Versus Observation for Moderate Hyperopia in Young Children (HTS1)
Hyperopia Treatment Study 1: Glasses versus Observation for Moderate Hyperopia in Young Children (HTS1)
Intermittent Exotrophia Study 5 (IXT5): A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Intermittent Exotrophia Study 6 (IXT6)
Intermittent Exotropia Study 2 (IXT2): A Randomized Clinical Trial of Observation Versus Occlusion Therapy for Intermittent Exotropia
Intermittent Exotropia Study 2 (IXT2): A Randomized Clinical Trial of Observation Versus Occlusion Therapy for Intermittent Exotropia
Intermittent Exotropia Study: A Pilot Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Myopia Treatment Study: Low Dose Atropine for Treatment of Myopia (MTS1)
Pediatric Eye Disease Investigator Group
Pediatric Eye Disease Investigator Group
Pediatric Eye Disease Investigator Group - MTS1
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Patching Vs Atropine For Amblyopia In 7 To <13 Years Olds - Amblyopia Treatment Study 9 (Ancillary Study)
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Atropine to Atropine Plus a Plano Lens for the Second Eye as Prescribed Treatments for Amblyopia in Children 3 to <7 Years Old (ATS 8)
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Near Versus Distance Activities While Patching for Amblyopia in Children 3 to <7 Years Old (ATS 6)
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Years Olds (ATS-9)
Pediatric Eye Disease Investigator Group: A Randomized Trial Comparing Patching with Active Vision Therapy to Patching with Control Vision Therapy as Treatment for Amblyopia in Children 7 to <13 Years Old (Feasibility Phase) - Amblyopia Treatment Study A12
Pediatric Eye Disease Investigator Group: A Randomized Trial of Full-Time Bangerter Filters Versus Part-Time Daily Patching for the Treatment of Moderate Amblyopia in Children - Amblyopia Treatment Study 10
Pediatric Eye Disease Investigator Group: A Randomized Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children 3 to <7 Years Old (ATS-5)
Pediatric Eye Disease Investigator Group: A Randomized Trial to Evaluate 8 Hours of Daily Patching Plus Daily Atropine for Rsidual Amblyopia in Children 3 to <8 Years Old - Amblyopia Treatment Study 11
Pediatric Eye Disease Investigator Group: Administrative Core
Pediatric Eye Disease Investigator Group: An Evaluation of Treatment of Amblyopia in Children 7 to <18 Years Old (ATS-3)
Pediatric Eye Disease Investigator Group: An Observational Study of Optical Correction for Strabismis Amblyopia in Children 3 to <7 Years Old - Amblyopia Treatment Study 13
Pediatric Eye Disease Investigator Group: Augmenting Atropine Treatment for Amblyopia (ATS 16)
Pediatric Eye Disease Investigator Group: Bilateral Refractive Amblyopia Treatment Study (ATS-7)
Pediatric Eye Disease Investigator Group: Correction of Refractive Error for Amblyopia Protocol (XO1)
Pediatric Eye Disease Investigator Group: Increasing Patching for Amblyopia (ATS15)
Pediatric Eye Disease Investigator Group: Intermittent Exotropia Study 2 (IXT2): A Randomized Clinical Trial of Observation Versus Occlusion Therapy for Intermittent Exotropia
Study of Binocular Computer Activities for Treatment of Amblyopia (ATS18)
Study: A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles plus Patching (ATS22) for the Pediatric Eye Disease Investigator Group (PEDIG)